Gladys Urbanowitz

Suggest Changes
Learn More
PURPOSE To assess the efficacy and safety of zoledronic acid in patients with bone metastases secondary to solid tumors other than breast or prostate cancer. PATIENTS AND METHODS Patients were(More)
Bone metastases in patients with renal cell carcinoma are associated with a high risk of skeletal complications. Therefore, a subset analysis of a larger clinical trial was performed to determine the(More)
TPS186 Background: Dovitinib (TKI258) is an oral investigational drug that inhibits angiogenic factors, including the fibroblast growth factor receptor (FGFR) and vascular endothelial growth factor(More)
  • 1